Home/Filings/4/0001213900-24-094663
4//SEC Filing

Dukes Iain D. 4

Accession 0001213900-24-094663

CIK 0001900520other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 6:00 PM ET

Size

5.7 KB

Accession

0001213900-24-094663

Insider Transaction Report

Form 4
Period: 2024-11-01
Dukes Iain D.
DirectorCEO and Chairman
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-11-01+2,096,6672,096,667 total
    Exercise: $1.30Exp: 2034-09-18Common Stock (2,096,667 underlying)
Footnotes (1)
  • [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.

Documents

1 file

Issuer

Lomond Therapeutics Holdings, Inc.

CIK 0001900520

Entity typeother

Related Parties

1
  • filerCIK 0001681955

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:00 PM ET
Size
5.7 KB